LivingGLP1
Study S000527

A Real-world Study of Liraglutide Alone and in Combination With Orlistat for Weight Loss in Overweight/Obese Patients.

Registration

Registration
NCT07301437
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Phase
PHASE4
Masking
NONE
Status
NOT_YET_RECRUITING
Enrollment
120
Start
2026-05-01
Primary completion
2027-08-31
Lead sponsor
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Conditions
Overweight and Obese Adults
Interventions
DRUG:liraglutide monotherapy; DRUG:liraglutide combined with orlistat
Results posted
FALSE

Registered primary outcomes

  • weight loss [6 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.